Johnathan Ebben
Impact in
-
- Cancer Cells and Metastasis
-
- Glioma Diagnosis and Treatment
Papers in
-
- vaccines and immunoinformatics approaches 2
- Epigenetics and DNA Methylation 1
- Oncology 5
- CAR-T cell therapy research 2
- Lung Cancer Research Studies 1
- Co-authors
- John S. Kuo (4 shared papers)Paul A. Clark (3 shared papers)Daniel M. Treisman (2 shared papers)Michael Zorniak (2 shared papers)Ming You (2 shared papers)Andreas Beyer (2 shared papers)Mary L. Disis (1 shared paper)Ekram Gad (1 shared paper)
- Journals
- npj Precision Oncology (1 paper)The International Journal of Biochemistry & Cell Biology (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Drugs (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Johnathan Ebben
11 papers receiving 339 citations
Peers
Comparison fields: 5 of 69
- Oncology 118
- Genetics 41
- Cancer Research 50
- Aging 5
- Molecular Biology 180
Countries citing papers authored by Johnathan Ebben
This map shows the geographic impact of Johnathan Ebben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnathan Ebben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnathan Ebben more than expected).
Fields of papers citing papers by Johnathan Ebben
This network shows the impact of papers produced by Johnathan Ebben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnathan Ebben. The network helps show where Johnathan Ebben may publish in the future.
Co-authors
The 25 scholars most cited alongside Johnathan Ebben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 78 | |
| 2 | 2018 | 59 | |
| 3 | 2007 | 55 | |
| 4 | 2011 | 39 | |
| 5 | 2015 | 29 | |
| 6 | 2016 | 29 | |
| 7 | 2016 | 25 | |
| 8 | 2021 | 23 | |
| 9 | 2009 | 7 | |
| 10 | 2018 | 4 | |
| 11 | 2025 | 3 | |
| 12 | 2024 | 0 |
About Johnathan Ebben
Johnathan Ebben is a scholar working on Molecular Biology, Oncology, Immunology, Physiology and Cardiology and Cardiovascular Medicine, having authored 12 papers that have together received 351 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), vaccines and immunoinformatics approaches (2 papers), Immune Cell Function and Interaction (2 papers), CAR-T cell therapy research (2 papers), Epigenetics and DNA Methylation (1 paper), Lung Cancer Research Studies (1 paper), Cardiac, Anesthesia and Surgical Outcomes (1 paper) and Telomeres, Telomerase, and Senescence (1 paper). The work is most often cited by research in Oncology (118 citations), Genetics (41 citations), Cancer Research (50 citations), Aging (5 citations) and Molecular Biology (180 citations). Johnathan Ebben has collaborated with scholars based in United States and China. Frequent co-authors include John S. Kuo, Paul A. Clark, Daniel M. Treisman, Michael Zorniak, Ming You, Andreas Beyer, Mary L. Disis, Ekram Gad, Karima Ait‐Aissa and Andrew O. Kadlec. Their work appears in journals such as npj Precision Oncology, The International Journal of Biochemistry & Cell Biology, Arteriosclerosis Thrombosis and Vascular Biology, Journal for ImmunoTherapy of Cancer and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.